
SurgiVision is a leading developer of MRI-guided interventional systems, creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital’s existing MRI suite, SurgiVision’s ClearPoint™ system is designed to enable a range of stereotactic procedures in the brain. In partnership with Siemens Healthcare, SurgiVision is developing the ClearTrace™ system to enable MRI-guided catheter ablations to treat cardiac arrhythmias. Building on the power of MRI, SurgiVision’s products strive to improve patient outcomes while reducing procedure costs and times.